Equity Research Report Sineng Electric (300827 CH) Overseas Expansion Boosted Earnings, Demand Poised to Rise | Huatai Research | Company Update | Rating (Maintain): | BUY | | --- | --- | --- | --- | | 14 May 2025 │ China (Mainland) | Power Equip & New Energy | Target price (RMB): | 34.00 | Sineng Electric's 2024 revenue/attributable net profit (NP) were RMB4,773/419mn (-3.2/+46.5% yoy), the latter missing our prior estimate of RMB503mn, mainly due to weaker shipments of PV inverters to domestic ground-moun ...

Zhejiang Longsheng's 1Q25 revenue/attributable net profit (NP)/recurring NP were RMB3.24/0.40/0.29bn (-7.2/+100.4/+3.5% yoy, -38.7/-41.5/-57.7% qoq). The 1Q25 attributable NP beat our prior forecast (RMB300mn), mainly driven by its property business. Maintain OVERWEIGHT, considering a demand recovery in dye and intermediate products and continued revenue contributions from property operations. Equity Research Report Zhejiang Longsheng (600352 CH) 1Q25 NP Improved Yoy, Property Business to Contribute Revenue ...

Equity Research Report General Healthy Info & Tech (605186 CH) Actively Expand Emerging Business, 1Q25 Revenue Growth Expedited | Huatai Research | Annual Results Review | Rating (Maintain): | BUY | | --- | --- | --- | --- | | 14 May 2025 │ China (Mainland) | Medical Devices | Target price (RMB): | 22.07 | General Healthy's (GH) revenue/attributable net profit (NP) were RMB318/33mn in 2024 (+3.5/-45.8% yoy), missing the Wind consensus of RMB381/127mn, primarily due to short-term disruptions in domestic dema ...